- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07670104
Acute Effects of Moderate-Intensity Swimming Exercise on Inhibitory Control, Cognitive Flexibility, and Selective Attention (SWIMCOG)
Acute Effects of Moderate-Intensity Freestyle Swimming Exercise on Inhibitory Control, Cognitive Flexibility, and Selective Attention: A Randomized Controlled Trial
This randomized controlled trial aims to investigate the acute effects of a single session of moderate-intensity freestyle swimming exercise on cognitive performance in healthy young adults. Cognitive functions such as inhibitory control, selective attention, and cognitive flexibility are essential components of executive functioning and play an important role in academic, occupational, and daily activities.
A total of 60 healthy adults aged 18-35 years will be randomly assigned to either an exercise group or a control group. Participants in the exercise group will complete a 30-minute session of moderate-intensity freestyle swimming, while participants in the control group will undergo passive seated rest for the same duration.
Cognitive performance will be evaluated immediately before and after the intervention using the Eriksen Flanker Task and the Stroop Color-Word Test. These assessments measure reaction time, attention control, information processing speed, and inhibitory control.
The study is designed to determine whether a single bout of swimming exercise can produce immediate improvements in executive functions compared with passive rest. Findings from this research may contribute to a better understanding of the relationship between aerobic exercise and cognitive performance and may help inform exercise-based strategies for enhancing cognitive health and performance in healthy individuals.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Istanbul
-
Istanbul, Istanbul, Turchia (Türkiye), 34290
- Istanbul Rumeli University, Faculty of Sport Sciences
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
Accetta volontari sani
Descrizione
Inclusion Criteria:
- Healthy adults aged 18 to 35 years.
- Normal or corrected-to-normal vision.
- Right-handed as determined by the Edinburgh Handedness Inventory.
- No history of neurological, psychiatric, or cardiovascular disorders.
- Engaging in structured exercise fewer than three times per week.
- Ability to safely participate in moderate-intensity swimming exercise.
- Provision of written informed consent.
Exclusion Criteria:
- Use of medications that may affect cognitive performance.
- Active musculoskeletal injury or pain limiting participation in exercise.
- Previous experience with the Eriksen Flanker Task or Stroop Color-Word Test.
- Contraindications to swimming exercise.
- Participation in vigorous physical activity within 24 hours before testing.
- Any medical condition considered unsafe for exercise participation by the investigators.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Scienza basilare
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: Experimental Group
Participants assigned to the experimental group completed a single 30-minute session of moderate-intensity freestyle swimming exercise.
The exercise protocol included a 5-minute warm-up, 20 minutes of continuous swimming at moderate intensity (approximately 60-70% of age-predicted maximum heart rate), and a 5-minute cool-down period.
|
A single session of moderate-intensity freestyle swimming lasting 30 minutes.
The protocol consisted of a 5-minute warm-up, 20 minutes of continuous freestyle swimming performed at approximately 60-70% of age-predicted maximum heart rate, and a 5-minute cool-down.
Exercise intensity was monitored using ratings of perceived exertion and heart rate measurements.
|
|
Nessun intervento: Control Group
Participants assigned to the control group remained seated at rest for 30 minutes in a quiet environment.
During this period, participants were instructed to avoid physical activity and cognitive stimulation.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Congruent Flanker Task Reaction Time
Lasso di tempo: Immediately before and immediately after the 30-minute intervention session
|
Mean reaction time during congruent trials of the Eriksen Flanker Task.
|
Immediately before and immediately after the 30-minute intervention session
|
|
Incongruent Flanker Task Reaction Time
Lasso di tempo: Immediately before and immediately after the 30-minute intervention session
|
Mean reaction time during incongruent trials of the Eriksen Flanker Task.
|
Immediately before and immediately after the 30-minute intervention session
|
|
Stroop Test Completion Time
Lasso di tempo: Immediately before and immediately after the 30-minute intervention session
|
Total completion time across the Stroop Color-Word Test (TBAG Form), assessing inhibitory control, selective attention, and cognitive flexibility.
|
Immediately before and immediately after the 30-minute intervention session
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- IRU-2026
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Funzione esecutiva
-
Paul SzabolcsReclutamentoMalattia granulomatosa cronica | Sindrome di DiGeorge | Disregolazione immunitaria | Immunodeficienza variabile comune (CVID) | Sindrome di Omen | Carenza di ligando CD40 | Suscettibilità mendeliana alla malattia micobatterica | Disturbo primario della regolazione immunitaria | STAT 1 Gain of Function | STAT... e altre condizioniStati Uniti